Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Preeclampsia Market Regional Analysis
The United States is projected to dominate the preeclampsia market share in the forecast period. The market value can be attributed to imparting significant focus on decreasing neonatal mortality rates due to premature delivery. With a well-equipped healthcare infrastructure, the government along with the key healthcare companies play a critical role in spreading awareness around early diagnosis of the condition. The rising prevalence of telehealth has bolstered market growth as patients adopt such solutions for immediate consultations.
Europe is a major market for preeclampsia treatment, offering innovative treatment options with the help of novel technologies. The presence of various academic institutions and research centers helps with market growth. Moreover, the increasing number of collaborative projects between universities and pharmaceutical companies is also helping the growth.
In Asia Pacific, Japan holds a substantial share of the market value. Yet, India and China, are projected to witness high preeclampsia market growth. This is because the regions are witnessing significantly more pregnancies than others, increasing the disease prevalence rate. In addition, there is a heightened focus on improving the healthcare infrastructure and developing better therapeutic strategies for the patients.
Preeclampsia Market Report Snapshots
Preeclampsia Regional Analysis
Preeclampsia Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, likely to be driven by the growing incidence of pregnancies along with increasing hypertension prevalence across major markets.
The market demand is majorly driven by the increasing incidence of hypertension in women owing to increased stressful, sedentary lifestyle and unhealthy dietary habits.
The current market trend revolves around high emphasis on early diagnosis of the disease for improved treatment alternatives. In September 2023, the researchers at Brown University and Western University conducted a study to reveal that the cis P-tau protein, which is commonly associated with neurological diseases such as stroke and Alzheimer’s disease may also be a biomarker for preeclampsia.
Based on treatment types, the market is divided into medication to lower B.P., corticosteroids and anticonvulsants medication.
The market is divided into mild and severe preeclampsia.
Major end users include hospitals, clinics, and others.
The major regions of the market include the United States, Japan, EU-4 which is segmented into Germany, France, Italy, Spain, and the United Kingdom.
Key players involved in the market are Thermo Fisher Scientific Inc., Baxter, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, PerkinElmer Inc., Sera Prognostics, DRG Instruments GMBH, Metabolomic Diagnostics, Diabetomics, Inc., Hitachi Ltd., Cardinal Health Inc., BioMerieux SA and Fujirebio Diagnostics.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124